Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Reid

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Barrett's esophagus: a model of human neoplastic progressionK Neshat, C A Sanchez, P C Galipeau, et al.
Pancreas|October 1, 1995
Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreasS Ramel, C A Sanchez, M K Schimke, et al.
Gastroenterology|January 1, 1988
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesionsB J Reid, W M Weinstein, K J Lewin, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Barrett's esophagus: ordering the events that lead to cancerB J Reid, M T Barrett, P C Galipeau, et al.
Cancer Research|November 24, 2001
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epitheliumD J Wong, T G Paulson, L J Prevo, et al.
Gastroenterology|November 1, 1991
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancerD S Levine, P S Rabinovitch, R C Haggitt, et al.
Annals of Internal Medicine|April 15, 2000
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagusR E Rudolph, T L Vaughan, B E Storer, et al.
IEEE Transactions on Bio-Medical Engineering|June 9, 2001
A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinomaA K Dattamajumbar, P L Blount, J A Myers, et al.
The American Journal of Gastroenterology|November 6, 2001
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progressionB J Reid, L J Prevo, P C Galipeau, et al.
Science (New York, N.Y.)|March 3, 1995
A p53-dependent mouse spindle checkpointS M Cross, C A Sanchez, C A Morgan, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Barrett's esophagus: a model of human neoplastic progressionK Neshat, C A Sanchez, P C Galipeau, et al.
Pancreas|October 1, 1995
Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreasS Ramel, C A Sanchez, M K Schimke, et al.
Gastroenterology|January 1, 1988
Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesionsB J Reid, W M Weinstein, K J Lewin, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1996
Barrett's esophagus: ordering the events that lead to cancerB J Reid, M T Barrett, P C Galipeau, et al.
Cancer Research|November 24, 2001
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epitheliumD J Wong, T G Paulson, L J Prevo, et al.
Gastroenterology|November 1, 1991
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancerD S Levine, P S Rabinovitch, R C Haggitt, et al.
Annals of Internal Medicine|April 15, 2000
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagusR E Rudolph, T L Vaughan, B E Storer, et al.
IEEE Transactions on Bio-Medical Engineering|June 9, 2001
A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinomaA K Dattamajumbar, P L Blount, J A Myers, et al.
The American Journal of Gastroenterology|November 6, 2001
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progressionB J Reid, L J Prevo, P C Galipeau, et al.
Science (New York, N.Y.)|March 3, 1995
A p53-dependent mouse spindle checkpointS M Cross, C A Sanchez, C A Morgan, et al.
Pageof 9